Ecabapide
Code | Size | Price |
---|
TAR-T31597-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T31597-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T31597-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Ecabapide is a novel pro-gastric motility agent that significantly enhanced gastric emptation of SHRSP. The effects of Ecabapide did not show rapid tolerance.
CAS:
104775-36-2
Formula:
C20H25N3O4
Molecular Weight:
371.437
Purity:
0.98
SMILES:
CNC(=O)c1cccc(NCC(=O)NCCc2ccc(OC)c(OC)c2)c1
References
1. Fujimaki Y, Hosokami T, Ono K. Identification of urinary metabolites of ecabapide in rat. Xenobiotica. 1995 May;25(5):501-10. PubMed PMID: 7571723.
2. Yokotani K, Okuma Y, Osumi Y. Alpha-2-adrenoceptor-mediated inhibition of vagally induced gastric acid secretion with the anti-ulcer agent DQ-2511. Jpn J Pharmacol. 1988 Oct;48(2):299-302. PubMed PMID: 2850383.
3. Hatanaka S, Ryokawa Y, Kawarabayashi K, Furuhama K. DQ-2511, having an antiulcer action, elicits vasodilation through an increase in cyclic GMP contents in rat arteries. Pharmacology. 1995 Sep;51(3):174-9. PubMed PMID: 7501703.
4. Furuhama K, Wood JD. Pharmacology of the gastric pro-kinetic drug ecabapide (DQ-2511). J Pharm Pharmacol. 1997 Dec;49(12):1168-74. Review. PubMed PMID: 9466337.